Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

ClinicalTrials.gov ID: NCT00890747

Public ClinicalTrials.gov record NCT00890747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 17, 2026, 1:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/Pharmacokinetic Study of Sunitinib in Patients With Cancer Who Also Have HIV and Are on HAART Therapy

Study identification

NCT ID: NCT00890747
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: National Cancer Institute (NCI); NIH
Enrollment: 42 participants

Conditions and interventions

Conditions

Interventions

laboratory biomarker analysis Other
pharmacological study Other
sunitinib malate Drug

Other · Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2009
Primary completion: Apr 30, 2011
Completion: Not listed
Last update posted: Mar 16, 2014

Started 2009

United States locations

U.S. sites: 11
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
Jonsson Comprehensive Cancer Center	Los Angeles	California	90095	—
Lombardi Comprehensive Cancer Center at Georgetown University	Washington D.C.	District of Columbia	20057	—
Northwestern University	Chicago	Illinois	60611	—
AIDS - Associated Malignancies Clinical Trials Consortium	Rockville	Maryland	20850	—
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	—
Washington University - Jewish	Saint Loius	Missouri	63110	—
Memorial Sloan Kettering Cancer Center	New York	New York	10065	—
Albert Einstein College of Medicine	The Bronx	New York	10461	—
Case Western Reserve University	Cleveland	Ohio	44106	—
Abramson Cancer Center of The University of Pennsylvania	Philadelphia	Pennsylvania	19104	—
Virginia Mason Medical Center	Seattle	Washington	98101	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00890747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 16, 2014 · Synced May 17, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00890747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →